Ganoderic acid a alleviates Aβ25-35-induced HT22 cell apoptosis through the ERK/MAPK pathway: a system pharmacology and in vitro experimental validation.

Ganoderma lucidum

OncologyImmune supportCognition & nervesMetabolic health

SpeciesReishi, Lingzhi

JournalMetabolic brain disease

Year2024

Metadata-grounded summary

Article summary

Metadata-grounded summary: This journal article indexes research on Ganoderma lucidum in Metabolic brain disease in 2024. MycoData maps the paper to oncology, immune support, cognition & nerves, metabolic health based on its title, species context, article metadata, and study classification.

Citation

Shao N, Lu Q, Ouyang Z, Yang P, Wei T, Wang J, et al. (2024). Ganoderic acid a alleviates Aβ25-35-induced HT22 cell apoptosis through the ERK/MAPK pathway: a system pharmacology and in vitro experimental validation. Metabolic brain disease https://doi.org/10.1007/s11011-024-01429-1 PMID: 39625499

Open citation